Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerhard Reichel

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Current Problems in Dermatology|December 11, 2002
Botulinum toxin A and the faceGerhard Reichel
Medizinische Monatsschrift Fur Pharmazeuten|May 1, 2009
[Muscle cramps--differential diagnosis and therapy]Gerhard Reichel
MMW Fortschritte Der Medizin|August 30, 2007
[Botulinum toxin: a new dimension for spasticity]Gerhard Reichel
Current Pharmaceutical Design|November 21, 2009
Current clinical applications of botulinum toxinDaniel D Truong, Andrea Stenner, Gerhard Reichel
Journal of Neural Transmission (Vienna, Austria : 1996)|August 18, 2012
Rating scales for cervical dystonia: a critical evaluation of tools for outcome assessment of botulinum toxin therapyWolfgang H Jost, Harald Hefter, Andrea Stenner, et al.
Pain Medicine (Malden, Mass.)|June 23, 2011
Botulinum type A toxin complex for the relief of upper back myofascial pain syndrome: how do fixed-location injections compare with trigger point-focused injections?Reiner Benecke, Axel Heinze, Gerhard Reichel, et al.
Pain|June 6, 2006
Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport) for the relief of upper back myofascial pain syndrome: results from a randomized double-blind placebo-controlled multicentre studyHartmut Göbel, Axel Heinze, Gerhard Reichel, et al.
Journal of the Neurological Sciences|June 20, 2015
Collum-caput (COL-CAP) concept for conceptual anterocollis, anterocaput, and forward sagittal shiftJosef Finsterer, Concha Maeztu, Gonzalo J Revuelta, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|December 17, 2010
Double-blind, randomised, parallel group pilot study comparing two botulinum toxin type A products for the treatment of blepharospasmBettina Wabbels, Gerhard Reichel, Antony Fulford-Smith, et al.
Fortschritte Der Neurologie-Psychiatrie|August 26, 2017
[Treatment of laryngeal dystonia with botulinum toxin]Arno Olthoff, Maria Grosheva, Gerhard Reichel, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Current Problems in Dermatology|December 11, 2002
Botulinum toxin A and the faceGerhard Reichel
Medizinische Monatsschrift Fur Pharmazeuten|May 1, 2009
[Muscle cramps--differential diagnosis and therapy]Gerhard Reichel
MMW Fortschritte Der Medizin|August 30, 2007
[Botulinum toxin: a new dimension for spasticity]Gerhard Reichel
Current Pharmaceutical Design|November 21, 2009
Current clinical applications of botulinum toxinDaniel D Truong, Andrea Stenner, Gerhard Reichel
Journal of Neural Transmission (Vienna, Austria : 1996)|August 18, 2012
Rating scales for cervical dystonia: a critical evaluation of tools for outcome assessment of botulinum toxin therapyWolfgang H Jost, Harald Hefter, Andrea Stenner, et al.
Pain Medicine (Malden, Mass.)|June 23, 2011
Botulinum type A toxin complex for the relief of upper back myofascial pain syndrome: how do fixed-location injections compare with trigger point-focused injections?Reiner Benecke, Axel Heinze, Gerhard Reichel, et al.
Pain|June 6, 2006
Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport) for the relief of upper back myofascial pain syndrome: results from a randomized double-blind placebo-controlled multicentre studyHartmut Göbel, Axel Heinze, Gerhard Reichel, et al.
Journal of the Neurological Sciences|June 20, 2015
Collum-caput (COL-CAP) concept for conceptual anterocollis, anterocaput, and forward sagittal shiftJosef Finsterer, Concha Maeztu, Gonzalo J Revuelta, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|December 17, 2010
Double-blind, randomised, parallel group pilot study comparing two botulinum toxin type A products for the treatment of blepharospasmBettina Wabbels, Gerhard Reichel, Antony Fulford-Smith, et al.
Fortschritte Der Neurologie-Psychiatrie|August 26, 2017
[Treatment of laryngeal dystonia with botulinum toxin]Arno Olthoff, Maria Grosheva, Gerhard Reichel, et al.
Pageof 2